These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36176937)

  • 1. Acute kidney injury associated to sulfamethoxazole urine crystal: The importance of clinical suspicion.
    Sepúlveda RA; Anghileri F; Huidobro E JP; Julio R; Ávila E; Figueroa C
    Clin Nephrol Case Stud; 2022; 10():71-75. PubMed ID: 36176937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfamethoxazole-induced crystal nephropathy: characterization and prognosis in a case series.
    Azencot R; Saint-Jacques C; Haymann JP; Frochot V; Daudon M; Letavernier E
    Sci Rep; 2024 Mar; 14(1):6078. PubMed ID: 38480876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible myoclonus, asterixis, and tremor associated with high dose trimethoprim-sulfamethoxazole: a case report.
    Gray DA; Foo D
    J Spinal Cord Med; 2016; 39(1):115-7. PubMed ID: 26111222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population.
    McLaughlin MM; Galal A; Richardson CL; Sutton SH; Barr VO; Patel N; Mitchell P; Stosor V
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28833985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methemoglobinemia induced by trimethoprim-sulfamethoxazole in a patient with systemic lupus erythematosus.
    Kawasumi H; Tanaka E; Hoshi D; Kawaguchi Y; Yamanaka H
    Intern Med; 2013; 52(15):1741-3. PubMed ID: 23903510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of risk factors for acute kidney injury among inpatients administered sulfamethoxazole/trimethoprim: a retrospective observational study.
    Shimizu Y; Hirai T; Ogawa Y; Yamada C; Kobayashi E
    J Pharm Health Care Sci; 2022 Aug; 8(1):20. PubMed ID: 35909129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
    J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
    BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia.
    Yang JJ; Huang CH; Liu CE; Tang HJ; Yang CJ; Lee YC; Lee KY; Tsai MS; Lin SW; Chen YH; Lu PL; Hung CC
    PLoS One; 2014; 9(9):e106141. PubMed ID: 25184238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
    Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-Sulfamethoxazole.
    Lee SM; Cho YK; Sung YM; Chung DH; Jeong SH; Park JW; Lee SP
    Korean J Parasitol; 2015 Jun; 53(3):321-7. PubMed ID: 26174826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
    Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
    Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.
    Gribble MJ; Puterman ML
    Am J Med; 1993 Aug; 95(2):141-52. PubMed ID: 8356980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions to trimethoprim-sulfamethoxazole in systemic lupus erythematosus.
    Izuka S; Yamashita H; Takahashi Y; Kaneko H
    Lupus; 2021 Sep; 30(10):1679-1683. PubMed ID: 34304628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim/Sulfamethoxazole-Induced Severe Lactic Acidosis: A Case Report and Review of the Literature.
    Bulathsinghala M; Keefer K; Van de Louw A
    Medicine (Baltimore); 2016 Apr; 95(17):e3478. PubMed ID: 27124045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
    Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
    J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for
    Awad M; Sierra CM; Mesghali E; Bahjri K
    J Oncol Pharm Pract; 2021 Dec; 27(8):1936-1939. PubMed ID: 33307970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
    Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
    Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study.
    Creemers-Schild D; Kroon FP; Kuijper EJ; de Boer MG
    Infection; 2016 Jun; 44(3):291-9. PubMed ID: 26471512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.